CLINICAL_TRIALS
withdrawal
· 2016-09-16
Clinical Trial Update: Melatonin for Prevention of Post- Operative Delirium Pilot Study Protocol [Phase 4]
Summary
A Phase 4 pilot study protocol evaluating melatonin for preventing postoperative delirium has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Loyola University | Conditions: Delirium | Phase 4 | Status: WITHDRAWN